Finanzen von GP-Act III Acquisition Corp (GPAT)GPATGP-Act III Acquisition Corp

Evaluating the bottom line, GP-Act III Acquisition Corp maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of 4.56%, provide a clear picture of how effectively GPAT converts its operational activities into shareholder value.

In the context of the broader market, GPAT competes directly with industry leaders such as ARCL and BLRK. With a market capitalization of $176.64M, it holds a significant position in the sector. When comparing efficiency, GPAT's gross margin of N/A stands against ARCL's N/A and BLRK's N/A. Such benchmarking helps identify whether GP-Act III Acquisition Corp is trading at a premium or discount relative to its financial performance.

The financial performance shows a declining trend in net income, with the latest figure at 290,121 for Q2 2026, down from 3,656,457 in Q3 2024. The EPS has also dropped to 0.01 in Q2 2026 from 0.10 in Q3 2024, indicating worsening profitability.